Sai Gourisankar, PhD is an NCI K99/R00 Postdoctoral Fellow at the Stanford Cancer Institute in the laboratory of Prof. Nathanael Gray. His PhD was in chemical engineering, advised by Prof. Gerald Crabtree, where he investigated mechanisms of epigenetic regulation in cancer and development. Dr. Gourisankar’s postdoctoral work focuses on developing new small molecule technologies to target and reprogram oncogenic drivers for therapeutic applications, particularly using chemical induced proximity approaches and enabled by biochemistry and genomics.
Dr. Gourisankar’s work has been covered by The New York Times, Endpoints, and Chemical & Engineering News, as well as editorials in Nature News and Views, Nature Chemical Biology, and Cancer Discovery.